XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 154 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $699,832 | -5.8% | 17,949 | +4.0% | 0.01% | 0.0% |
| Q1 2024 | $743,086 | -8.1% | 17,261 | -1.7% | 0.01% | -16.7% |
| Q4 2023 | $808,445 | +63.5% | 17,552 | +21.2% | 0.01% | +50.0% |
| Q3 2023 | $494,568 | -9.3% | 14,478 | +2.2% | 0.00% | 0.0% |
| Q2 2023 | $545,353 | +12.1% | 14,165 | +4.2% | 0.00% | 0.0% |
| Q1 2023 | $486,422 | -6.4% | 13,591 | +3.1% | 0.00% | -20.0% |
| Q4 2022 | $519,569 | +15.7% | 13,177 | +6.0% | 0.01% | 0.0% |
| Q3 2022 | $449,000 | +40.8% | 12,427 | +18.4% | 0.01% | +66.7% |
| Q2 2022 | $319,000 | -6.5% | 10,497 | -5.9% | 0.00% | 0.0% |
| Q1 2022 | $341,000 | +2.1% | 11,156 | +4.5% | 0.00% | 0.0% |
| Q4 2021 | $334,000 | – | 10,679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,754,266 | $107,388,831 | 7.33% |
| Altium Capital Management LP | 360,600 | $14,059,794 | 5.74% |
| Affinity Asset Advisors, LLC | 994,227 | $38,764,911 | 4.47% |
| First Light Asset Management, LLC | 1,306,260 | $50,931,077 | 4.46% |
| Nan Fung Group Holdings Ltd | 106,680 | $4,159,453 | 4.44% |
| Ally Bridge Group (NY) LLC | 169,369 | $6,603,697 | 3.93% |
| TLS Advisors LLC | 32,956 | $1,285 | 3.22% |
| BRAIDWELL LP | 2,560,573 | $99,836,741 | 3.13% |
| Paradigm Biocapital Advisors LP | 2,043,280 | $79,667,487 | 3.05% |
| BRIDGER MANAGEMENT, LLC | 146,800 | $5,723,732 | 2.94% |